Strong bipartisan support for controlled psilocybin use as treatment or enhancement in a representative sample of US Americans: need for caution in public policy persists

Please use this identifier to cite or link to this item: https://doi.org/10.1080/21507740.2024.2303154

DC Field	Value
dc.title	Strong bipartisan support for controlled psilocybin use as treatment or enhancement in a representative sample of US Americans: need for caution in public policy persists
dc.contributor.author	Julian David Sandbrink
dc.contributor.author	Kyle Johnson
dc.contributor.author	Maureen Gill
dc.contributor.author	David Yaden
dc.contributor.author	Julian Savulescu
dc.contributor.author	Ivar R. Hannikainen
dc.contributor.author	Brian D. Earp
dc.date.accessioned	2024-05-06T02:58:04Z
dc.date.available	2024-05-06T02:58:04Z
dc.date.issued	2024-02-05
dc.identifier.citation	Julian David Sandbrink, Kyle Johnson, Maureen Gill, David Yaden, Julian Savulescu, Ivar R. Hannikainen, Brian D. Earp (2024-02-05). Strong bipartisan support for controlled psilocybin use as treatment or enhancement in a representative sample of US Americans: need for caution in public policy persists. AJOB Neuroscience 15 (2) : 82-89. ScholarBank@NUS Repository. https://doi.org/10.1080/21507740.2024.2303154
dc.identifier.issn	2150-7740
dc.identifier.uri	https://scholarbank.nus.edu.sg/handle/10635/248262
dc.publisher	Taylor & Francis
dc.source	Taylor & Francis
dc.type	Others
dc.contributor.department	DEAN'S OFFICE (MEDICINE)
dc.description.doi	10.1080/21507740.2024.2303154
dc.description.sourcetitle	AJOB Neuroscience
dc.description.volume	15
dc.description.issue	2
dc.description.page	82-89
Appears in Collections:	Staff Publications Elements

File	Description	Size	Format	Access Settings	Version
10.108021507740.2024.2303154.zip		1.3 MB	ZIP	OPEN	None	View/Download

Check